About FDA

NCTR Research Highlights

Red envelope icon for GovdeliveryGet e-mail updates when this information changes.

Current Highlight from November 14, 2014

Progress on FDA Studies Reviewed

The 44th meeting of the Toxicology Study Selection and Review Committee (TSSRC) was held November 12-13, 2014, at FDA’s White Oak facility, to discuss ongoing studies that are part of the Interagency Agreement between FDA/NCTR and the National Institute of Environmental Health Sciences/National Toxicology Program (NIEHS/NTP) that supports toxicology studies providing data for the FDA risk assessment process.

Ongoing studies at NCTR in the following areas were discussed:

  • Food contaminants (Bisphenol A; melamine + cyanuric acid; nanosilver)
  • Topically applied compounds (retinyl palmitate; oxybenzone)
  • Antibacterial chemicals (triclosan)
  • Medical device components (nanosilver)
  • Dietary supplement component (aloe vera)

The NIEHS/NTP presented updates on the NTP and the NIEHS/NTP Toxicology Testing Program. 

The TSSRC is comprised of regulatory scientists and subject-matter experts from the FDA Centers (CBER, CDER, CDRH, CFSAN, CVM, and CTP), NIEHS/NTP, and the National Institutes of Health.  The committee meets twice each year and is responsible for scientific oversight of study design and progress of ongoing work under this Interagency Agreement.  The next meeting of the TSSRC will be held at the FDA White Oak campus, May 6-7, 2015. 

For additional information, please contact Paul C. Howard, Ph.D., Director, Office of Scientific Coordination, FDA/NCTR.

Contact FDA

National Center for Toxicological Research

Food and Drug Administration

3900 NCTR Road

Jefferson, AR 72079

Page Last Updated: 11/15/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.